Skip to main content
. 2022 Jun 27;31(2):114–122. doi: 10.4274/mirt.galenos.2022.73636

Table 4. Significant difference in circulating angiogenic factor levels of patients with and without progression of the treated liver lobe at the 6th week of follow-up.

graphic file with name MIRT-31-114-g9.jpg